Topics: Advocacy
News
-
-
ACTA—a year in review, 2018-2019 financial year
-
Nominations extended for ACTA Trial of the Year Awards
-
ACTA statement on COVID-19
-
Tweetchats with PRAXIS and ACTA
-
National Medical Stockpile: Supply of experimental medicines to support clinical trials
-
Australian Clinical Trials Alliance celebrating and honouring clinical trials on International Clinical Trials Day
-
ACTA STInG: signatories to open letters addressing statistical analysis and data integrity in COVID-19 publications
-
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
-
Continuity of Care Collaboration (CCC) Forum – Rural and Remote Health
-
ARDC HeSANDA Australian Data Partnerships Program: Open Call
-
White Coats Foundation: Power of One Campaign
-
Parliamentary Inquiry into approval processes for new drugs and novel medical technologies in Australia
-
National One-Stop-Shop
-
National Clinical Trials Governance Framework Pilot: Update
-
ACSQHC – National One-Stop-Shop Survey
-
Research Australia web consultation
-
Clinical Trials – Phase 2 Advisory Committee Communique – Meeting 6, 1 October 2021
-
ACTA welcomes inquiry findings into the approval processes for new drugs and novel medical technologies in Australia
-
New MRFF Strategy and Priorities released
-
Media Release: PHRP Excellence Awards – Highly Commended In Practice paper
-
2023 ACTA International Clinical Trials Symposium
-
ACTA welcomes $1.89b investment in Australian health and medical research including support for a National One Stop Shop